Bill Status of HB4821  100th General Assembly


Short Description:  INS CODE-STAGE 4 CANCER DRUGS

House Sponsors
Rep. Laura Fine, Katie Stuart, John Connor, Sam Yingling, Robyn Gabel, Jonathan Carroll, Michelle Mussman, Deb Conroy, William Davis, Stephanie A. Kifowit, Sue Scherer, Mary E. Flowers, Gregory Harris, Marcus C. Evans, Jr. and Al Riley

Senate Sponsors
(Sen. Julie A. Morrison - Pamela J. Althoff - Jacqueline Y. Collins - Terry Link - Mattie Hunter, Linda Holmes, Kwame Raoul, John G. Mulroe and Laura M. Murphy)

Last Action
DateChamber Action
  8/24/2018HousePublic Act . . . . . . . . . 100-1057

Statutes Amended In Order of Appearance
5 ILCS 375/6.11
55 ILCS 5/5-1069.3
65 ILCS 5/10-4-2.3
105 ILCS 5/10-22.3f
215 ILCS 5/356z.29 new
215 ILCS 125/5-3from Ch. 111 1/2, par. 1411.2
215 ILCS 130/4003from Ch. 73, par. 1504-3
215 ILCS 165/10from Ch. 32, par. 604
305 ILCS 5/5-16.8


Synopsis As Introduced
Amends the Illinois Insurance Code. Provides that no individual or group policy of accident and health insurance amended, issued, delivered, or renewed in the State after the effective date of the amendatory Act that covers the treatment of stage 4 advanced, metastatic cancer shall limit or exclude coverage for a drug by mandating that the insured shall first be required to fail to successfully respond to a different drug or prove a history of failure of the drug unless the use of the drug is consistent with best practices for the treatment of stage 4 advanced, metastatic cancer and is supported by peer-reviewed medical literature. Makes conforming changes in the State Employee Group Insurance Act of 1971, the Counties Code, the Illinois Municipal Code, the School Code, the Health Maintenance Organization Act, the Limited Health Service Organization Act, the Voluntary Health Services Plans Act, and the Illinois Public Aid Code.

House Floor Amendment No. 1
In provisions amending the Illinois Insurance Code concerning a policy that covers the treatment of stage 4 advanced, metastatic cancer, prohibits the policy from limiting or excluding coverage for a drug by mandating that the insured shall first be required to fail to successfully respond to a different drug or prove a history of failure of the drug as long as (rather than unless) the use of the drug is consistent with best practices for the treatment of stage 4 advanced, metastatic cancer and is supported by peer-reviewed medical literature.

Senate Committee Amendment No. 1
In provisions amending the Illinois Insurance Code, provides that a provision concerning the prohibition of coverage restrictions or exclusions for the treatment of stage 4 advanced, metastatic cancer is inoperative other than any such coverage authorized under specified provisions of the Social Security Act and the State shall not assume any obligation for the cost of the prohibition of coverage restrictions or exclusions for the treatment of stage 4 advanced, metastatic cancer if, at any time, the Secretary of the United States Department of Health and Human Services, or its successor agency, promulgates rules or regulations to be published in the Federal Register, publishes a comment in the Federal Register, or issues an opinion, guidance, or other action that would require the State, pursuant to any provision of the Patient Protection and Affordable Care Act, to defray the cost of that prohibition of coverage restrictions or exclusions.

Actions 
DateChamber Action
  2/14/2018HouseFiled with the Clerk by Rep. Laura Fine
  2/14/2018HouseFirst Reading
  2/14/2018HouseReferred to Rules Committee
  3/8/2018HouseAdded Co-Sponsor Rep. Katie Stuart
  3/8/2018HouseAdded Co-Sponsor Rep. John Connor
  3/8/2018HouseAdded Co-Sponsor Rep. Sam Yingling
  3/8/2018HouseAdded Co-Sponsor Rep. Robyn Gabel
  3/21/2018HouseAssigned to Insurance: Health & Life Committee
  4/9/2018HouseDo Pass / Short Debate Insurance: Health & Life Committee; 011-001-000
  4/10/2018HousePlaced on Calendar 2nd Reading - Short Debate
  4/23/2018HouseHouse Floor Amendment No. 1 Filed with Clerk by Rep. Laura Fine
  4/23/2018HouseHouse Floor Amendment No. 1 Referred to Rules Committee
  4/24/2018HouseHouse Floor Amendment No. 1 Rules Refers to Insurance: Health & Life Committee
  4/25/2018HouseHouse Floor Amendment No. 1 Recommends Be Adopted Insurance: Health & Life Committee; 012-001-000
  4/25/2018HouseSecond Reading - Short Debate
  4/25/2018HouseHouse Floor Amendment No. 1 Adopted
  4/25/2018HousePlaced on Calendar Order of 3rd Reading - Short Debate
  4/25/2018HouseAdded Co-Sponsor Rep. Jonathan Carroll
  4/25/2018HouseAdded Co-Sponsor Rep. Michelle Mussman
  4/25/2018HouseAdded Co-Sponsor Rep. Deb Conroy
  4/25/2018HouseAdded Co-Sponsor Rep. William Davis
  4/25/2018HouseAdded Co-Sponsor Rep. Stephanie A. Kifowit
  4/25/2018HouseAdded Co-Sponsor Rep. Sue Scherer
  4/25/2018HouseAdded Co-Sponsor Rep. Mary E. Flowers
  4/25/2018HouseAdded Co-Sponsor Rep. Gregory Harris
  4/27/2018HouseAdded Co-Sponsor Rep. Marcus C. Evans, Jr.
  4/27/2018HouseThird Reading - Short Debate - Passed 092-000-000
  4/27/2018HouseAdded Co-Sponsor Rep. Al Riley
  5/1/2018SenateArrive in Senate
  5/1/2018SenatePlaced on Calendar Order of First Reading
  5/1/2018SenateChief Senate Sponsor Sen. Julie A. Morrison
  5/1/2018SenateFirst Reading
  5/1/2018SenateReferred to Assignments
  5/2/2018SenateAdded as Alternate Chief Co-Sponsor Sen. Pamela J. Althoff
  5/2/2018SenateAdded as Alternate Chief Co-Sponsor Sen. Jacqueline Y. Collins
  5/2/2018SenateAdded as Alternate Chief Co-Sponsor Sen. Terry Link
  5/2/2018SenateAssigned to Insurance
  5/2/2018SenateAdded as Alternate Chief Co-Sponsor Sen. Mattie Hunter
  5/9/2018SenateSenate Committee Amendment No. 1 Filed with Secretary by Sen. Julie A. Morrison
  5/9/2018SenateSenate Committee Amendment No. 1 Referred to Assignments
  5/9/2018SenateSenate Committee Amendment No. 1 Assignments Refers to Insurance
  5/9/2018SenateSenate Committee Amendment No. 1 Adopted
  5/10/2018SenateDo Pass as Amended Insurance; 012-000-000
  5/10/2018SenatePlaced on Calendar Order of 2nd Reading May 15, 2018
  5/10/2018SenateAdded as Alternate Co-Sponsor Sen. Linda Holmes
  5/17/2018SenateSecond Reading
  5/17/2018SenatePlaced on Calendar Order of 3rd Reading May 18, 2018
  5/17/2018SenateAdded as Alternate Co-Sponsor Sen. Kwame Raoul
  5/17/2018SenateAdded as Alternate Co-Sponsor Sen. John G. Mulroe
  5/22/2018SenateAdded as Alternate Co-Sponsor Sen. Laura M. Murphy
  5/24/2018SenateThird Reading - Passed; 053-000-001
  5/24/2018HouseArrived in House
  5/24/2018HousePlaced on Calendar Order of Concurrence Senate Amendment(s) 1
  5/24/2018HouseSenate Committee Amendment No. 1 Motion Filed Concur Rep. Laura Fine
  5/24/2018HouseSenate Committee Amendment No. 1 Motion to Concur Referred to Rules Committee
  5/28/2018HouseSenate Committee Amendment No. 1 Motion to Concur Recommends Be Adopted Rules Committee; 004-000-000
  5/31/2018HouseSenate Committee Amendment No. 1 House Concurs 109-000-000
  5/31/2018HouseHouse Concurs
  5/31/2018HousePassed Both Houses
  6/29/2018HouseSent to the Governor
  8/24/2018HouseGovernor Approved
  8/24/2018HouseEffective Date January 1, 2019
  8/24/2018HousePublic Act . . . . . . . . . 100-1057